At least in so far as the understanding of human disease is concerned, the use of the experimental animal approach is primarily to find a model with sufficient similarity to the abnormalities observable in the human condition to give some assurance that insights obtained from these studies will give valuable clues to the nature of the human process. Certainly from animal models useful information can be obtained which can guide clinical thought at a variety of levels. In order of importance for control and management these are: etiological; pathogenical; diagnostic, including physiological, biochemical, histological, and cytological potentials; prognostic as to reversibility, vicious cycle mechanisms, etc.; and therapeutic.
The worth of an experimental model depends to a great extent on its similarity to the human counterpart and to a lesser degree on the consistency with which it can be produced. When a model is found that rates high in these characteristics, it is often possible, by interrupting the experiments, to describe a sequential development of the processes and thus assign a higher priority to certain steps in the pathogenesis and factors in etiology over that assigned to others. In this way, it.may also be possible to derive rather conclusive evidence as to the truly pathogenic findings and the crucial etiologic factors. Once these qualitative studies have been performed, the next step is usually to find some type of quantitative relationship between the stressors and the endpoint, or endpoints, which appear to be most important. Two features of the quantitative relationship of greatest importance are whether there is a threshold before any effect is seen and whether there is an all-or-none response or a graded one once a sufficient dose has been reached.
Certainly for the greatest understanding of the pathogenesis, the earlier in the process and the more discrete the endpoint the better.
When multiple agents are used in the experimental situation, the problem becomes more complex. A broad definition of synergy may be used to describe any situation in which two or more agents appear to give some type of result over and above that for either agent alone. A much more exacting definition requires that the result from multiple agents should * Professor of Preventive Medicine, University of Illinois. Executive Vice President, Professional and Academic Affairs, Presbyterian-St. Luke's Hospital. exceed that expected from the summation of the effects of the agents involved. In Table 1 , various relationships are given for two agents. With more than two, the above definition would pertain but the analysis would be more complex.
In the situation in which multiple agents are involved, the definition of the endpoint becomes more important than that for single agents. When a condition results qualitatively from two agents, when neither alone has given any abnormality, as found by Boren' for carbon particles and NO2, the total process may be used as the endpoint. To derive further information, the quantitative relationship between each agent and each discrete pathologic process is needed in order to differentiate whether the drugs are acting together through a common mechanism, or whether each is giving rise to one part of the process and the composite is recognizable as similar to the human condition. For example, the association between chronic bronchitis and emphysema is not well understood but it has been described that either may occur in the absence of the other. However, these descriptions have implied that the pure form of either is quite unusual and the rule is an element of each.' This association is more frequent than would be expected by a chance coincidence based upon the frequency of each condition. Unless there were a very small percentage of the population who were susceptible to each and that it was the same segment of the population for both, the expected frequency of the dual condition would be much less than either pure form. Thus, if one agent, for example bacteria, caused chronic bronchitis in animals, and a second agent, such as another bacteria, However, if each endpoint were analyzed separately with appropriate dose-effect curves, it would be possible to separate the etiology of the two processes. On the other hand, if a combination of gases or particles behaved in such a way that they could initiate an autoimmune mechanism, perhaps by a haptene action with both bronchial components and alveolar components, a single agent (the haptene) may result in both processes; yet the analysis of each endpoint separately might still allow separation of the processes were the dose-effect curves for each tissue component different.
As seen in the Table, part I-A, the analyses of the relationship between agents vary with the nature of the dose-effect curves for each of the agents in terms of each endpoint. The four possible relationships listed are given from similar definitions used in describing actions of combinations of drugs, but rather than using favorable outcome as the endpoint, damage or death is used in this situation. This type of analysis is important for situations such as two gases in the atmosphere or a gas in cigarette smoke and another in air pollution. Epidemiologic studies suggest that there is a dose-effect curve for these last two factors. Figure 1 illustrates the importance of precise definitions in describing combined actions. In panels 1 and 2, it can be seen that agents A and B may have somewhat similar dose-effect curves but because neither one of them is linear, it is not possible to add points on them to get estimates of the results expected by summation. For example, in panel 3, it can be seen that if the same gas were used under different codes such as A and B and the levels of activity such as the 20 per cent effective dose (E.D.20) of each were found and they were added (i.e. dose doubled), an 80 per cent result would be achieved and synergy in the restricted sense of category IA-4 in the Table would be surmised, even though it was the same drug being used twice. However, if a function of the dose and/or a function of the effect could be found which would allow the description of a linear relationship on a wide range, addition of the expected effects could legitimately be made.
It is important, however, that for each agent the effect be expressed in terms of the same function. From the two curves shown in panels 4 and 5, data are available which allow the construction of a series of lines such as those in panel 6, best described as ISO-effect curves. Thus the 80 per cent effective line is the locus of all dose relationships that add together to be that effective (i.e., 40% effective for A + 40%o for B, 30%o A and 50%o B, were obtained, this would indicate more than either alone but less than complete addition. If 60 per cent effect were found as indicated by "X," it would be complete addition; and if "3" were obtained, a true synergy would exist.
From experience with mixed bacterial infections, when there are sufficient data to make this type of analysis, less than complete addition is seen more frequently than any other result. As seen in Figure 2 , part 1, this usually means that the agents are acting through unrelated mechanisms and the fact that complete addition does not occur indicates, for example, that some of the 25 per cent of the animals most susceptible to A are among the 25 per cent most susceptible to B. Of course, if each of the animals most susceptible to A had the same rank order susceptibility to B, then no addition would occur and a separate mechanism but one with a parallel susceptibility would have to be postulated. If the agents acted through an identical mechanism with a final common path, then they would behave, once the corrections had been made for the slopes and intercepts of the dose-effect curves by using the linear plots and their E.D. values, with complete addition (part 2). If the mechanism were exactly the same as it would be with the same drug used twice, the dose-effect plots would have the same threshold and slope. Complete addition would also occur in a situation in which the susceptibility of the two mechanisms were reciprocal as seen in part 3. These two types of biologic relationships that allow for complete addition would have to be separated by some type of stratification of the hosts by a third criterion if one could be found. Thus, it is possible, if the endpoint is discrete and a dose-effect curve is derived, to make some inferences about the mechanisms through which the agent acts.
The endpoint used can be at the end of a sequence if it is the final common path from the loci of actions when the drugs act at the same step. It is often possible to test for this by varying the time relationship between the administrations of the agents.
In a mixed renal infection,8 it was shown that when Staphylococcus aureus and Candida albicans were administered simultaneously, the results (deaths) were less than expected by complete addition but more than expected for either organism alone. However, when the Staphylococcus was given in a low effective dose, a week before the Candida, it could antagonize the latter. This implies that the sequence is altered when Staphylococcal administration preceded Candida but not when they were given concur-AGENT WITH SUBQUANTAL DOSE ACTING WITH AGENT WITH DOSE-EFFECT CURVE rently. This type of analysis should be particularly helpful in studying the interrelationships between inanimate chemicals or between microbes such as bacteria nad viruses, provided a dose-effect curve for a common endpoint can be found for each agent. The same model can be used for several atmospheric pollutants measured simultaneously in epidemiological studies.
In the experimental situation additional information may be gained by altering the time relationship in addition to the dose. When one of the agents has no demonstrable dose-effect curve but only a threshold with an all-or-none response, the situation listed in the Table under "B" may be found as illustrated in Figure 3 . In panel 1, the dose- is not as precise a definition as the one above and not as much can be inferred from it about pathogenesis. If B were antagonistic to A, the threshold would be increased and/or the slope lessened as seen in panel 3. In a situation such as the one encountered by Boren,1 neither agent has a dose-effect curve and both may be quantal. In this situation, the observations have qualitative but little quantitative significance. Variation of time relationships might allow some inferences, however. In a review of a large number of inhalation experiments which have been reported it was found that the vast majority had insufficient definition of endpoints, dose, or time controls to do more than describe a qualitative picture, thus disallowing analysis of the significance of a combination of agents.
One additional problem is that of the measuring of the dose in the doseeffect curve. For example, the infection of an animal with tuberculosis by inhalation is actually a quantal phenomenon if tuberculin sensitization is used as the endpoint, but can be quantitated if the tubercle counts are made on the alveolar membranes. If one used only conversion or ultimate death once the original tubercle had spread, the dose response derived would merely reflect the innoculum size necessary to get impingement by one inhaled particle of the correct size on the alveolar membrane. In Boren's experiment the particle-gas association may be a single effective agent and a dose-effect curve would reflect this if studied in a time perspective.
As indicated under heading II in the Table, if there are several endpoints involved and each agent plays a role in each, the situation may become quite complex, but careful analysis will allow each situation to be dissected out.
Thus problems like superinfection versus mixed infection in which each of the agents in the mixture is involved may be separately defined if variation in quantitation of an endpoint can be shown to change when the time relationship between the administration of each of the agents is made. Thus concurrent administration of two organisms may give results greatly different from those from sequential administration. As indicated by Dr.
Austrian,' the mixed infection situation is the one most frequently encountered in the lower airway contamination.
SUMMARY
Interpretation of the action of more than agent is considerably more difficult than that of a single agent. Careful attention to dose-effect curves
